Researchers are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans

Large and diverse data sets help clinical labs tailor treatments

For the first time in the U.S., a blood test will be available to help doctors determine if people who've experienced a blow to the head could have a traumatic brain injury 

Researchers have shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer

New Scripps research study offers guidance for more effective Ebola vaccines

For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia to understand how this blood cancer responds to a new drug, enasidenib

Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against Tuberculosis, the world's leading infectious disease killer

Drug extends survival, reverses some neuromuscular damage in animals

The results reveal that tumors are much more complex than previously appreciated

NIPD can reduce the number of procedure-related miscarriages

The quantitative suspension array assays developed by ISGlobal researchers could simplify sero-epidemiological studies and vaccine development

Sepsis is an infection that kills as many Americans each year as stroke and Alzheimer's combined